On March 9, AroCell, Anders Hultman CEO, presented the latest developments and the future of the company at the Stockholm Corporate Finance Life Science Capital Markets Days at the IVA conference center in Stockholm. Stockholm Corporate Finance arranged the capital...
News
News
Kampen mot cancer samarbete – Så kan nya blodtestet hjälpa läkare avgöra om terapin fungera
CEO, Anders Hultman, Commenting on FDA delay due to Covid-19
This weekend the US Food and Drug Administration (FDA) has informed that the impact of the COVID-19 pandemic and the reallocation of staff is leading to an even greater prolonged timeline for reviews of submissions. Anders Hultman, CEO of AroCell, commenting the FDA...
Commenting CEO Transition, interview by Redeye
(In Swedish)
IDL Biotech licenses its manual ELISA tumor marker product line to Beckman Coulter Diagnostics
IDL Biotech wants to focus on rapid diagnostic tests and automated assays of its tumor markers. By licensing the platform ELISA to Beckman Coulter, we can focus our resources on streamlining and developing the other platforms, said Gunnar Wahlberg, CEO of IDL...
IDL Biotech develops rapid test for breast cancer
In recent years IDL Biotech has been working on developing a rapid test to detect lung cancer, under the project name MonoTotal® Rapid. However, further development will instead focus on creating a rapid test for breast cancer. Read the article here (Swedish)
AroCell TK 210 ELISA can now be used on automated platforms
Quantification of Thymidine Kinase 1 in serum with AroCell TK 210 ELISA is now validated for use on an open automation platform for ELISA. This enhances the application and use of the assay. We have now validated AroCell TK 210 ELISA for use on an automation platform,...
Redeye interview with Michael Brobjer
A new Redeye interview with Michael Brobjer, AroCell CEO, commenting interim report for the second quarter of 2020. See the interview on Redeye's website.
Business Development Manager Asia
IDL Biotech has appointed Subyung Park as Business Development Manager Asia with a focus on the product TUBEX® TF. Read the press release here
New research note on AroCells previous analysis from Redeye
Redeye has today released a new research note on the previous analysis of Arocell. The full report can be found on their website. Link to Redeye's new research note.